NF-κB mediated miR-21 regulation in cardiomyocytes apoptosis under oxidative stress

References

• Tsutsui H, Kinugawa S, Matsushima S. Oxidative stress and heart failure. Am J Physiol Heart Circ Physiol 2011;301: H2181–H2190.
   PubMed Web of Science ®Google Scholar
• Crawford DR, Davies KJ. Adaptive response and oxidative stress. Environ Health Perspect 1994;102:25–28.
   PubMed Web of Science ®Google Scholar
• Pashkow FJ. Oxidative stress and inflammation in heart disease: do antioxidants have a role in treatment and/or prevention?. Int J Inflam 2011;2011:514623.
   PubMedGoogle Scholar
• Afanas'ev I. ROS and RNS signaling in heart disorders: could antioxidant treatment be successful?. Oxid Med Cell Longev 2011;2011:293769.
   PubMed Web of Science ®Google Scholar
• Jun HO, Kim DH, Lee SW, Lee HS, Seo JH, Kim JH, et al. Clusterin protects H9c2 cardiomyocytes from oxidative stress-induced apoptosis via Akt/GSK-3beta signaling pathway. Exp Mol Med 2011;43:53–61.
   PubMed Web of Science ®Google Scholar
• Park ES, Kang JC, Kang DH, Jang YC, Yi KY, Chung HJ, et al. 5-AIQ inhibits H2O2-induced apoptosis through reactive oxygen species scavenging and Akt/GSK-3beta signaling pathway in H9c2 cardiomyocytes. Toxicol Appl Pharmacol 2013;268:90–98.
   PubMed Web of Science ®Google Scholar
• Wei C, Kumar S, Kim IK, Gupta S. Thymosin beta 4 protects cardiomyocytes from oxidative stress by targeting anti-oxidative enzymes and anti-apoptotic genes. PLoS One 2012;7:e42586.
   PubMed Web of Science ®Google Scholar
• Essick EE, Ouchi N, Wilson RM, Ohashi K, Ghobrial J, Shibata R, et al. Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling. Am J Physiol Heart Circ Physiol 2011;301:H984–993.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Huang WD, Lv XY, Yang YM. Ghrelin protects H9c2 cells from hydrogen peroxide-induced apoptosis through NF-kappaB and mitochondria-mediated signaling. Eur J Pharmacol 2011;654:142–149.
   PubMed Web of Science ®Google Scholar
• Young D, Popovic ZB, Jones WK, Gupta S. Blockade of NF-kappaB using IkappaB alpha dominant-negative mice ameliorates cardiac hypertrophy in myotrophin-overexpressed transgenic mice. J Mol Biol 2008;381:559–568.
   PubMed Web of Science ®Google Scholar
• Gupta S, Purcell NH, Lin A, Sen S. Activation of nuclear factor-kappaB is necessary for myotrophin-induced cardiac hypertrophy. J Cell Biol 2002;159:1019–1028.
   PubMed Web of Science ®Google Scholar
• Gaspar-Pereira S, Fullard N, Townsend PA, Banks PS, Ellis EL, Fox C, et al. The NF-kappaB subunit c-Rel stimulates cardiac hypertrophy and fibrosis. Am J Pathol 2012; 180:929–939.
   PubMed Web of Science ®Google Scholar
• Van der Heiden K, Cuhlmann S, Luong le A, Zakkar M, Evans PC. Role of nuclear factor kappaB in cardiovascular health and disease. Clin Sci (Lond) 2010;118:593–605.
   PubMed Web of Science ®Google Scholar
• Hamid T, Guo SZ, Kingery JR, Xiang X, Dawn B, Prabhu SD. Cardiomyocyte NF-kappaB p65 promotes adverse remodelling, apoptosis, and endoplasmic reticulum stress in heart failure. Cardiovasc Res 2011;89:129–138.
   PubMed Web of Science ®Google Scholar
• Rao PK, Toyama Y, Chiang HR, Gupta S, Bauer M, Medvid R, et al. Loss of cardiac microRNA-mediated regulation leads to dilated cardiomyopathy and heart failure. Circ Res 2009;105:585–594.
   PubMed Web of Science ®Google Scholar
• Wang K, Lin ZQ, Long B, Li JH, Zhou J, Li PF. Cardiac hypertrophy is positively regulated by MicroRNA miR-23a. J Biol Chem 2012;287:589–599.
   PubMed Web of Science ®Google Scholar
• Zhu H, Fan GC. Role of microRNAs in the reperfused myocardium towards post-infarct remodelling. Cardiovasc Res 2012;94:284–292.
   PubMed Web of Science ®Google Scholar
• Latronico MV, Condorelli G. Therapeutic use of microRNAs in myocardial diseases. Curr Heart Fail Rep 2011;8: 193–197.
   PubMedGoogle Scholar
• Bagnall RD, Tsoutsman T, Shephard RE, Ritchie W, Semsarian C. Global microRNA profiling of the mouse ventricles during development of severe hypertrophic cardiomyopathy and heart failure. PLoS One 2012;7:e44744.
   Web of Science ®Google Scholar
• Fiedler J, Thum T. MicroRNAs in myocardial infarction. Arterioscler Thromb Vasc Biol 2013;33:201–205.
   PubMed Web of Science ®Google Scholar
• Pan X, Wang ZX, Wang R. MicroRNA-21: a novel therapeutic target in human cancer. Cancer Biol Ther 2010;10: 1224–1232.
   PubMed Web of Science ®Google Scholar
• Jazbutyte V, Thum T. MicroRNA-21: from cancer to cardiovascular disease. Curr Drug Targets 2010;11:926–935.
   PubMed Web of Science ®Google Scholar
• Roy S, Khanna S, Hussain SR, Biswas S, Azad A, Rink C, et al. MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc Res 2009;82:21–29.
   PubMed Web of Science ®Google Scholar
• da Costa Martins PA, De Windt LJ. miR-21: a miRaculous Socratic paradox. Cardiovasc Res 2010;87:397–400.
   PubMed Web of Science ®Google Scholar
• Patrick DM, Montgomery RL, Qi X, Obad S, Kauppinen S, Hill JA, et al. Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice. J Clin Invest 2010; 120:3912–3916.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Zhang C. MicroRNA-21 in cardiovascular disease. J Cardiovasc Transl Res 2010;3:251–255.
   PubMed Web of Science ®Google Scholar
• Zhou J, Wang KC, Wu W, Subramaniam S, Shyy JY, Chiu JJ, et al. MicroRNA-21 targets peroxisome proliferators-activated receptor-alpha in an autoregulatory loop to modulate flow-induced endothelial inflammation. Proc Natl Acad Sci U S A 2011;108:10355–10360.
   PubMed Web of Science ®Google Scholar
• Dong S, Cheng Y, Yang J, Li J, Liu X, Wang X, et al. MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction. J Biol Chem 2009;284:29514–29525.
   PubMed Web of Science ®Google Scholar
• Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008;456:980–984.
   PubMed Web of Science ®Google Scholar
• Tatsuguchi M, Seok HY, Callis TE, Thomson JM, Chen JF, Newman M, et al. Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J Mol Cell Cardiol 2007;42:1137–1141.
   PubMed Web of Science ®Google Scholar
• Wei C, Kim IK, Kumar S, Jayasinghe S, Hong N, Catalucci D, et al. NF-kappaB mediated miR-26a regulation in cardiac fibrosis. J Cell Physiol 2013;228:1433–1442.
   PubMed Web of Science ®Google Scholar
• Kumar S, Gupta S. Thymosin beta 4 prevents oxidative stress by targeting antioxidant and anti-apoptotic genes in cardiac fibroblasts. PLoS One 2011;6:e26912.
   PubMed Web of Science ®Google Scholar
• Park KJ, Kim YJ, Kim J, Kim SM, Lee SY, Bae JW, et al. Protective effects of peroxiredoxin on hydrogen peroxide induced oxidative stress and apoptosis in cardiomyocytes. Korean Circ J 2012;42:23–32.
   PubMed Web of Science ®Google Scholar
• Seddon M, Looi YH, Shah AM. Oxidative stress and redox signalling in cardiac hypertrophy and heart failure. Heart 2007;93:903–907.
   PubMed Web of Science ®Google Scholar
• Dorn GW, 2nd. Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling. Cardiovasc Res 2009;81:465–473.
   PubMed Web of Science ®Google Scholar
• Takano H, Zou Y, Hasegawa H, Akazawa H, Nagai T, Komuro I. Oxidative stress-induced signal transduction pathways in cardiac myocytes: involvement of ROS in heart diseases. Antioxid Redox Signal 2003;5:789–794.
   PubMed Web of Science ®Google Scholar
• Kratsios P, Huth M, Temmerman L, Salimova E, Al Banchaabouchi M, Sgoifo A, et al. Antioxidant amelioration of dilated cardiomyopathy caused by conditional deletion of NEMO/IKKgamma in cardiomyocytes. Circ Res 2010;106:133–144.
   PubMed Web of Science ®Google Scholar
• Gallogly MM, Shelton MD, Qanungo S, Pai HV, Starke DW, Hoppel CL, et al. Glutaredoxin regulates apoptosis in cardiomyocytes via NFkappaB targets Bcl-2 and Bcl-xL: implications for cardiac aging. Antioxid Redox Signal 2010; 12:1339–1353.
   PubMed Web of Science ®Google Scholar
• Topkara VK, Mann DL. Role of microRNAs in cardiac remodeling and heart failure. Cardiovasc Drugs Ther 2011; 25:171–182.
   PubMed Web of Science ®Google Scholar
• Huang ZP, Neppl RL, Wang DZ. MicroRNAs in cardiac remodeling and disease. J Cardiovasc Transl Res 2010;3: 212–218.
   PubMed Web of Science ®Google Scholar
• Kumarswamy R, Volkmann I, Thum T. Regulation and function of miRNA-21 in health and disease. RNA Biol 2011; 8:706–713.
   PubMed Web of Science ®Google Scholar
• Ma X, Becker Buscaglia LE, Barker JR, Li Y. MicroRNAs in NF-kappaB signaling. J Mol Cell Biol 2011;3:159–166.
   PubMed Web of Science ®Google Scholar
• Niu J, Shi Y, Tan G, Yang CH, Fan M, Pfeffer LM, Wu ZH. DNA damage induces NF-kappaB-dependent microRNA-21 up-regulation and promotes breast cancer cell invasion. J Biol Chem 2012;287:21783–21795.
   PubMed Web of Science ®Google Scholar
• Zhou R, Hu G, Gong AY, Chen XM. Binding of NF-kappaB p65 subunit to the promoter elements is involved in LPS- induced transactivation of miRNA genes in human biliary epithelial cells. Nucleic Acids Res 2010;38:3222–3232.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Liu X, Zhang S, Lin Y, Yang J, Zhang C. MicroRNA-21 protects against the H(2)O(2)-induced injury on cardiac myocytes via its target gene PDCD4. J Mol Cell Cardiol 2009;47:5–14.
   PubMed Web of Science ®Google Scholar
• Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, Lund AH. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 2008;283:1026–1033.
   PubMed Web of Science ®Google Scholar
• Song J, Hu B, Qu H, Bi C, Huang X, Zhang M. Mechanical stretch modulates microRNA 21 expression, participating in proliferation and apoptosis in cultured human aortic smooth muscle cells. PLoS One 2012;7:e47657.
   Web of Science ®Google Scholar
• Lu Z, Liu M, Stribinskis V, Klinge CM, Ramos KS, Colburn NH, Li Y. MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene 2008;27:4373–4379.
   PubMed Web of Science ®Google Scholar
• Young MR, Yang HS, Colburn NH. Promising molecular targets for cancer prevention: AP-1, NF-kappa B and Pdcd4. Trends Mol Med 2003;9:36–41.
   PubMed Web of Science ®Google Scholar
• Li R, Yan G, Li Q, Sun H, Hu Y, Sun J, Xu B. MicroRNA-145 protects cardiomyocytes against hydrogen peroxide (H(2)O(2))-induced apoptosis through targeting the mitochondria apoptotic pathway. PLoS One 2012;7:e44907.
   PubMed Web of Science ®Google Scholar
• Lin Y, Liu X, Cheng Y, Yang J, Huo Y, Zhang C. Involvement of MicroRNAs in hydrogen peroxide-mediated gene regulation and cellular injury response in vascular smooth muscle cells. J Biol Chem 2009;284:7903–7913.
   PubMed Web of Science ®Google Scholar
• Hulsmans M, De Keyzer D, Holvoet P. MicroRNAs regulating oxidative stress and inflammation in relation to obesity and atherosclerosis. FASEB J 2011;25:2515–2527.
   PubMed Web of Science ®Google Scholar
• Quarrie R, Lee DS, Steinbaugh G, Cramer B, Erdahl W, Pfeiffer DR, et al. Ischemic preconditioning preserves mitochondrial membrane potential and limits reactive oxygen species production. J Surg Res 2012;178:8–17.
   PubMed Web of Science ®Google Scholar
• Kadenbach B, Ramzan R, Moosdorf R, Vogt S. The role of mitochondrial membrane potential in ischemic heart failure. Mitochondrion 2011;11:700–706.
   PubMed Web of Science ®Google Scholar
• Zhang GX, Lu XM, Kimura S, Nishiyama A. Role of mitochondria in angiotensin II-induced reactive oxygen species and mitogen-activated protein kinase activation. Cardiovasc Res 2007;76:204–212.
   PubMed Web of Science ®Google Scholar